ZA201009036B - Novel dual targeting antitumoural conjugates - Google Patents
Novel dual targeting antitumoural conjugatesInfo
- Publication number
- ZA201009036B ZA201009036B ZA2010/09036A ZA201009036A ZA201009036B ZA 201009036 B ZA201009036 B ZA 201009036B ZA 2010/09036 A ZA2010/09036 A ZA 2010/09036A ZA 201009036 A ZA201009036 A ZA 201009036A ZA 201009036 B ZA201009036 B ZA 201009036B
- Authority
- ZA
- South Africa
- Prior art keywords
- antitumoural
- conjugates
- novel dual
- dual targeting
- targeting
- Prior art date
Links
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 230000009977 dual effect Effects 0.000 title 1
- 230000008685 targeting Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08156575 | 2008-05-20 | ||
| PCT/EP2009/055653 WO2009141240A1 (en) | 2008-05-20 | 2009-05-11 | Novel dual targeting antitumoural conjugates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201009036B true ZA201009036B (en) | 2012-01-25 |
Family
ID=39765065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2010/09036A ZA201009036B (en) | 2008-05-20 | 2010-12-15 | Novel dual targeting antitumoural conjugates |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20110160147A1 (https=) |
| EP (1) | EP2285396A1 (https=) |
| JP (1) | JP2011523415A (https=) |
| KR (1) | KR20110022594A (https=) |
| CN (1) | CN102036676A (https=) |
| AR (1) | AR071840A1 (https=) |
| AU (1) | AU2009249795A1 (https=) |
| BR (1) | BRPI0911978A2 (https=) |
| CA (1) | CA2724562A1 (https=) |
| EA (1) | EA201071326A1 (https=) |
| IL (1) | IL208920A0 (https=) |
| MX (1) | MX2010012320A (https=) |
| NZ (1) | NZ588948A (https=) |
| TW (1) | TW201004647A (https=) |
| WO (1) | WO2009141240A1 (https=) |
| ZA (1) | ZA201009036B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7985401B2 (en) | 2003-10-31 | 2011-07-26 | The Regents Of The University Of California | Peptides whose uptake by cells is controllable |
| CA2770980A1 (en) | 2009-07-15 | 2011-01-20 | Roger Y. Tsien | Peptides whose uptake in cells is controllable |
| CA2816041C (en) * | 2010-12-29 | 2019-01-08 | Arrowhead Research Corporation | In vivo polynucleotide delivery conjugates having enzyme sensitive linkages |
| CA2841249C (en) | 2011-07-29 | 2023-09-26 | Avelas Biosciences, Inc. | Selective delivery molecules and methods of use |
| US10029017B2 (en) | 2013-01-29 | 2018-07-24 | The Regents Of The University Of California | Pretargeted activatable cell penetrating peptide with intracellularly releasable prodrug |
| EA031930B1 (ru) | 2013-01-30 | 2019-03-29 | Авелас Байосайенсиз, Инк. | Молекула селективной доставки для визуализации злокачественной ткани |
| CN103333227B (zh) * | 2013-06-07 | 2015-10-07 | 东南大学 | 转移肿瘤缺失蛋白小分子环肽抑制剂及其制备方法与应用 |
| WO2015095227A2 (en) | 2013-12-16 | 2015-06-25 | Genentech, Inc. | Peptidomimetic compounds and antibody-drug conjugates thereof |
| WO2016008112A1 (en) * | 2014-07-16 | 2016-01-21 | Medshine Discovery Inc. | Linkers and application towards adc thereof |
| US10385380B2 (en) | 2014-10-02 | 2019-08-20 | The Regents Of The University Of California | Personalized protease assay to measure protease activity in neoplasms |
| US10125124B2 (en) | 2015-03-20 | 2018-11-13 | Massachusetts Institute Of Technology | Formation of macromolecules using iterative growth and related compounds |
| US10596259B2 (en) | 2015-05-20 | 2020-03-24 | The Regents Of The University Of California | Tumor radiosensitization with monomethyl auristatin E (MMAE) and derivatives thereof |
| CN108064246A (zh) | 2015-06-15 | 2018-05-22 | 基因泰克公司 | 抗体和免疫结合物 |
| EA202191244A1 (ru) * | 2018-11-05 | 2021-10-11 | Байер Фарма Акциенгезельшафт | Новые цитостатические конъюгаты с лигандами интегрина |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2370245A1 (en) * | 1999-05-14 | 2000-11-23 | Boehringer Ingelheim Pharmaceuticals, Inc. | Enzyme-activated anti-tumor prodrug compounds |
| ITRM20040240A1 (it) * | 2004-05-13 | 2004-08-13 | Ist Naz Stud Cura Dei Tumori | Camptotecine coniugate in posizione 7 con antagonisti delle integrine. |
| US8404650B2 (en) * | 2005-10-28 | 2013-03-26 | The Regents Of The University Of Colorado, A Body Corporate | Methods of treating cancer with doxazolidine and prodrugs thereof |
-
2009
- 2009-05-04 TW TW098114716A patent/TW201004647A/zh unknown
- 2009-05-11 EA EA201071326A patent/EA201071326A1/ru unknown
- 2009-05-11 BR BRPI0911978A patent/BRPI0911978A2/pt not_active IP Right Cessation
- 2009-05-11 AU AU2009249795A patent/AU2009249795A1/en not_active Abandoned
- 2009-05-11 KR KR1020107027835A patent/KR20110022594A/ko not_active Withdrawn
- 2009-05-11 CA CA2724562A patent/CA2724562A1/en not_active Abandoned
- 2009-05-11 NZ NZ588948A patent/NZ588948A/en not_active IP Right Cessation
- 2009-05-11 EP EP09749730A patent/EP2285396A1/en not_active Withdrawn
- 2009-05-11 JP JP2011509923A patent/JP2011523415A/ja active Pending
- 2009-05-11 CN CN200980118231XA patent/CN102036676A/zh active Pending
- 2009-05-11 MX MX2010012320A patent/MX2010012320A/es not_active Application Discontinuation
- 2009-05-11 WO PCT/EP2009/055653 patent/WO2009141240A1/en not_active Ceased
- 2009-05-19 AR ARP090101790A patent/AR071840A1/es unknown
- 2009-09-02 US US12/993,738 patent/US20110160147A1/en not_active Abandoned
-
2010
- 2010-10-25 IL IL208920A patent/IL208920A0/en unknown
- 2010-12-15 ZA ZA2010/09036A patent/ZA201009036B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201004647A (en) | 2010-02-01 |
| CN102036676A (zh) | 2011-04-27 |
| EA201071326A1 (ru) | 2011-06-30 |
| JP2011523415A (ja) | 2011-08-11 |
| MX2010012320A (es) | 2010-12-01 |
| NZ588948A (en) | 2011-10-28 |
| IL208920A0 (en) | 2011-01-31 |
| AU2009249795A1 (en) | 2009-11-26 |
| WO2009141240A1 (en) | 2009-11-26 |
| KR20110022594A (ko) | 2011-03-07 |
| US20110160147A1 (en) | 2011-06-30 |
| EP2285396A1 (en) | 2011-02-23 |
| BRPI0911978A2 (pt) | 2019-09-24 |
| AR071840A1 (es) | 2010-07-21 |
| CA2724562A1 (en) | 2009-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL208920A0 (en) | Novel dual targeting antitumoural conjugates | |
| IL284184A (en) | Oligosaccharide-protein conjugates | |
| IL211180B (en) | Attached polyethylene glycol and docetaxel | |
| IL216719A0 (en) | Pure-peg-lipid conjugates | |
| ZA201100532B (en) | Predictive geo-temporal advertisement targeting | |
| EP2176821A4 (en) | ADVERTISING TARGETING IN VIDEO | |
| IL211933A0 (en) | Novel fused aminodihydrothiazine derivative | |
| GB0918579D0 (en) | Gadd45beta targeting agents | |
| IL208990A0 (en) | Novel phenylimidazopyrazines | |
| IL210053A0 (en) | Crkl targeting peptides | |
| IL212474A0 (en) | Novel uses | |
| EP2249646A4 (en) | PDE4 muscarinic Antagonist-DOPPELPHARMACOPHOREN | |
| GB0806978D0 (en) | Novel formulations | |
| IL207352A0 (en) | Dual pharmacophores - pde4 - muscarinic antagonistics | |
| IL207351A0 (en) | Dual pharmacophores - pde4 - muscarinic antagonistics | |
| IL199718A0 (en) | Peptide-complement conjugates | |
| GB0818328D0 (en) | Novel enzyme | |
| IL207346A0 (en) | Dual pharmacophores - pde4 - muscarinic antagonistics | |
| EP2249830A4 (en) | DUAL PHARMACOPHORES, ANTAGONISTS OF MUSCARINIC RECEPTORS AND INHIBITORS OF PDE4 ACTIVITY | |
| EP2334985A4 (en) | BURNER | |
| GB0906023D0 (en) | Insulin-Nanoparticle conjugates | |
| GB201018548D0 (en) | Burner improvement | |
| GB0821076D0 (en) | Modified linkers | |
| GB0802978D0 (en) | Modified linkers | |
| GB0806310D0 (en) | Novel envelope |